ARCHIVES

Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

CTI Files Appeal Over FDA’s Decision on Pixantrone

December 3, 2010

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

AACR Presents 2014 Awards, Arteaga Becomes President at Annual Meeting

April 11, 2014

Univ. of Iowa Cancer Center Wins NCI Cancer Center Grant.

July 28, 2000

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

November 5, 1993